遺伝子デリバリーシステムの世界市場レポート2024-2030
英文タイトル: Global Gene Delivery System Market Insights, Forecast to 2030
販売価格(消費税別)
個人版
マルチユーザー版
企業版
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=147.60円。
※米ドル表示価格+10%消費税。
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=147.60円。
※米ドル表示価格+10%消費税。
※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
概要
本報告書は、遺伝子デリバリーシステムの世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に遺伝子デリバリーシステム市場を分類しています。本レポートでは世界の遺伝子デリバリーシステム市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は:Biogen、Novartis、Gilead Sciences、Sarepta Therapeutics、Alnylam Pharmaceuticals、Amgen、Spark Therapeutics、Akcea Therapeutics、bluebird bio、Sunway Biotech、SIBIONO、AnGes、Orchard Therapeutics、Human Stem Cells Institute
レポートは遺伝子デリバリーシステムの主要生産者を調査し、主要地域や国の消費状況も提供します。遺伝子デリバリーシステムの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。
2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。タイプ別市場セグメント:
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別(地域レベル、国レベル)の遺伝子デリバリーシステム生産量、成長率、市場シェアを調査している。
Viral Gene Delivery System
Non-viral Gene Delivery System
用途別の市場セグメント:
Neurological Diseases
Cancer
Others
本レポートの詳細内容
本レポートは、世界の遺伝子デリバリーシステム市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて遺伝子デリバリーシステム市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
二. 消費面では、遺伝子デリバリーシステムの売上高を地域別(地域レベル・国レベル)、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。
三.主要メーカーの遺伝子デリバリーシステム売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界の遺伝子デリバリーシステム市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。
四.本遺伝子デリバリーシステムのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。
章の概要第1章:遺伝子デリバリーシステムのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー(タイプ別およびアプリケーション別など)を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。(2020~2031)
第2章: 遺伝子デリバリーシステムの世界と主要生産者(地域/国)の生産/アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。(2020~2031)
第3章:世界、地域、国レベルにおける遺伝子デリバリーシステムの売上(消費)、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。(2020~2031)
第4章遺伝子デリバリーシステムメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。(2020~2025)
第5章:遺伝子デリバリーシステムの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(2020~2031)
第6章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。(2020~2031)
第7章:北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の売上高、収益。(2020~2031)
第8章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高と収益。(2020~2031)
第9章:中国:タイプ別、アプリケーション別、セグメント別の売上高、収益。(2020~2031)
第10章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別の売上高、収益。(2020~2031)
第11章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別の売上高、収益。(2020~2031)
第12章:遺伝子デリバリーシステムの主要メーカーの概要を提供し、製品の説明と仕様、遺伝子デリバリーシステムの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。(2020~2025)
第13章:産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章:遺伝子デリバリーシステムの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章:レポートの要点と結論。
概要
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery. Market Analysis and Insights: Global Gene Delivery System Market The global Gene Delivery System market is projected to grow from US$ 9197.1 million in 2024 to US$ 39700 million by 2030, at a Compound Annual Growth Rate (CAGR) of 27.6% during the forecast period. Gene Delivery System is widely used for Neurological Diseases, Cancer, etc. The Neurological Diseases occupied about 60% of market share, the cancer occupied about 35%. North America is the largest consumption place, with a consumption market share nearly 62% in 2019. Following North America, Europe and Asia-Pacific occupied about 35% revenue market share in 2019. Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen,Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute and etc. are the leaders of the industry. In 2019,top 3 companies occupied over 80% of revenue market share. Report Covers: This report presents an overview of global market for Gene Delivery System market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. This report researches the key producers of Gene Delivery System, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Gene Delivery System, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries. This report focuses on the Gene Delivery System revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Gene Delivery System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Gene Delivery System revenue, projected growth trends, production technology, application and end-user industry. Market Segmentation By Company Biogen Novartis Gilead Sciences Sarepta Therapeutics Alnylam Pharmaceuticals Amgen Spark Therapeutics Akcea Therapeutics bluebird bio Sunway Biotech SIBIONO AnGes Orchard Therapeutics Human Stem Cells Institute Segment by Type Viral Gene Delivery System Non-viral Gene Delivery System Segment by Application Neurological Diseases Cancer Others By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia India Latin America, Middle East & Africa Brazil Mexico Turkey Israel GCC Countries Chapter Outline Chapter Outline Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Revenue of Gene Delivery System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 3: Detailed analysis of Gene Delivery System companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment. Chapter 7: Europe by Type, by Application and by country, revenue for each segment. Chapter 8: China by Type, and by Application, revenue for each segment. Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment. Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment. Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Delivery System revenue, gross margin, and recent development, etc. Chapter 12: Analyst's Viewpoints/Conclusions
総目録
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Delivery System Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Viral Gene Delivery System
1.2.3 Non-viral Gene Delivery System
1.3 Market by Application
1.3.1 Global Gene Delivery System Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Delivery System Market Perspective (2019-2030)
2.2 Global Gene Delivery System Growth Trends by Region
2.2.1 Gene Delivery System Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Delivery System Historic Market Size by Region (2019-2024)
2.2.3 Gene Delivery System Forecasted Market Size by Region (2025-2030)
2.3 Gene Delivery System Market Dynamics
2.3.1 Gene Delivery System Industry Trends
2.3.2 Gene Delivery System Market Drivers
2.3.3 Gene Delivery System Market Challenges
2.3.4 Gene Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Gene Delivery System by Players
3.1.1 Global Gene Delivery System Revenue by Players (2019-2024)
3.1.2 Global Gene Delivery System Revenue Market Share by Players (2019-2024)
3.2 Global Gene Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gene Delivery System, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Gene Delivery System Market Concentration Ratio
3.4.1 Global Gene Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Delivery System Revenue in 2023
3.5 Global Key Players of Gene Delivery System Head office and Area Served
3.6 Global Key Players of Gene Delivery System, Product and Application
3.7 Global Key Players of Gene Delivery System, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Delivery System Breakdown Data by Type
4.1 Global Gene Delivery System Historic Market Size by Type (2019-2024)
4.2 Global Gene Delivery System Forecasted Market Size by Type (2025-2030)
5 Gene Delivery System Breakdown Data by Application
5.1 Global Gene Delivery System Historic Market Size by Application (2019-2024)
5.2 Global Gene Delivery System Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Delivery System Market Size (2019-2030)
6.2 North America Gene Delivery System Market Size by Type
6.2.1 North America Gene Delivery System Market Size by Type (2019-2024)
6.2.2 North America Gene Delivery System Market Size by Type (2025-2030)
6.2.3 North America Gene Delivery System Market Share by Type (2019-2030)
6.3 North America Gene Delivery System Market Size by Application
6.3.1 North America Gene Delivery System Market Size by Application (2019-2024)
6.3.2 North America Gene Delivery System Market Size by Application (2025-2030)
6.3.3 North America Gene Delivery System Market Share by Application (2019-2030)
6.4 North America Gene Delivery System Market Size by Country
6.4.1 North America Gene Delivery System Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Gene Delivery System Market Size by Country (2019-2024)
6.4.3 North America Gene Delivery System Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Gene Delivery System Market Size (2019-2030)
7.2 Europe Gene Delivery System Market Size by Type
7.2.1 Europe Gene Delivery System Market Size by Type (2019-2024)
7.2.2 Europe Gene Delivery System Market Size by Type (2025-2030)
7.2.3 Europe Gene Delivery System Market Share by Type (2019-2030)
7.3 Europe Gene Delivery System Market Size by Application
7.3.1 Europe Gene Delivery System Market Size by Application (2019-2024)
7.3.2 Europe Gene Delivery System Market Size by Application (2025-2030)
7.3.3 Europe Gene Delivery System Market Share by Application (2019-2030)
7.4 Europe Gene Delivery System Market Size by Country
7.4.1 Europe Gene Delivery System Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Gene Delivery System Market Size by Country (2019-2024)
7.4.3 Europe Gene Delivery System Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Gene Delivery System Market Size (2019-2030)
8.2 China Gene Delivery System Market Size by Type
8.2.1 China Gene Delivery System Market Size by Type (2019-2024)
8.2.2 China Gene Delivery System Market Size by Type (2025-2030)
8.2.3 China Gene Delivery System Market Share by Type (2019-2030)
8.3 China Gene Delivery System Market Size by Application
8.3.1 China Gene Delivery System Market Size by Application (2019-2024)
8.3.2 China Gene Delivery System Market Size by Application (2025-2030)
8.3.3 China Gene Delivery System Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Gene Delivery System Market Size (2019-2030)
9.2 Asia Gene Delivery System Market Size by Type
9.2.1 Asia Gene Delivery System Market Size by Type (2019-2024)
9.2.2 Asia Gene Delivery System Market Size by Type (2025-2030)
9.2.3 Asia Gene Delivery System Market Share by Type (2019-2030)
9.3 Asia Gene Delivery System Market Size by Application
9.3.1 Asia Gene Delivery System Market Size by Application (2019-2024)
9.3.2 Asia Gene Delivery System Market Size by Application (2025-2030)
9.3.3 Asia Gene Delivery System Market Share by Application (2019-2030)
9.4 Asia Gene Delivery System Market Size by Region
9.4.1 Asia Gene Delivery System Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Gene Delivery System Market Size by Region (2019-2024)
9.4.3 Asia Gene Delivery System Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Gene Delivery System Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Gene Delivery System Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gene Delivery System Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Gene Delivery System Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Gene Delivery System Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Gene Delivery System Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gene Delivery System Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Gene Delivery System Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Gene Delivery System Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Gene Delivery System Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gene Delivery System Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Gene Delivery System Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Gene Delivery System Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Delivery System Introduction
11.1.4 Biogen Revenue in Gene Delivery System Business (2019-2024)
11.1.5 Biogen Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Delivery System Introduction
11.2.4 Novartis Revenue in Gene Delivery System Business (2019-2024)
11.2.5 Novartis Recent Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene Delivery System Introduction
11.3.4 Gilead Sciences Revenue in Gene Delivery System Business (2019-2024)
11.3.5 Gilead Sciences Recent Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene Delivery System Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene Delivery System Business (2019-2024)
11.4.5 Sarepta Therapeutics Recent Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene Delivery System Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2019-2024)
11.5.5 Alnylam Pharmaceuticals Recent Developments
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene Delivery System Introduction
11.6.4 Amgen Revenue in Gene Delivery System Business (2019-2024)
11.6.5 Amgen Recent Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Details
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene Delivery System Introduction
11.7.4 Spark Therapeutics Revenue in Gene Delivery System Business (2019-2024)
11.7.5 Spark Therapeutics Recent Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene Delivery System Introduction
11.8.4 Akcea Therapeutics Revenue in Gene Delivery System Business (2019-2024)
11.8.5 Akcea Therapeutics Recent Developments
11.9 bluebird bio
11.9.1 bluebird bio Company Details
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Gene Delivery System Introduction
11.9.4 bluebird bio Revenue in Gene Delivery System Business (2019-2024)
11.9.5 bluebird bio Recent Developments
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Details
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Gene Delivery System Introduction
11.10.4 Sunway Biotech Revenue in Gene Delivery System Business (2019-2024)
11.10.5 Sunway Biotech Recent Developments
11.11 SIBIONO
11.11.1 SIBIONO Company Details
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Gene Delivery System Introduction
11.11.4 SIBIONO Revenue in Gene Delivery System Business (2019-2024)
11.11.5 SIBIONO Recent Developments
11.12 AnGes
11.12.1 AnGes Company Details
11.12.2 AnGes Business Overview
11.12.3 AnGes Gene Delivery System Introduction
11.12.4 AnGes Revenue in Gene Delivery System Business (2019-2024)
11.12.5 AnGes Recent Developments
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Details
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Gene Delivery System Introduction
11.13.4 Orchard Therapeutics Revenue in Gene Delivery System Business (2019-2024)
11.13.5 Orchard Therapeutics Recent Developments
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Details
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Gene Delivery System Introduction
11.14.4 Human Stem Cells Institute Revenue in Gene Delivery System Business (2019-2024)
11.14.5 Human Stem Cells Institute Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
表と図のリスト
List of Tables Table 1. Global Gene Delivery System Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030 Table 2. Key Players of Viral Gene Delivery System Table 3. Key Players of Non-viral Gene Delivery System Table 4. Global Gene Delivery System Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030 Table 5. Global Gene Delivery System Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 6. Global Gene Delivery System Market Size by Region (2019-2024) & (US$ Million) Table 7. Global Gene Delivery System Market Share by Region (2019-2024) Table 8. Global Gene Delivery System Forecasted Market Size by Region (2025-2030) & (US$ Million) Table 9. Global Gene Delivery System Market Share by Region (2025-2030) Table 10. Gene Delivery System Market Trends Table 11. Gene Delivery System Market Drivers Table 12. Gene Delivery System Market Challenges Table 13. Gene Delivery System Market Restraints Table 14. Global Gene Delivery System Revenue by Players (2019-2024) & (US$ Million) Table 15. Global Gene Delivery System Revenue Share by Players (2019-2024) Table 16. Global Top Gene Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Delivery System as of 2023) Table 17. Global Gene Delivery System Industry Ranking 2022 VS 2023 VS 2024 Table 18. Global 5 Largest Players Market Share by Gene Delivery System Revenue (CR5 and HHI) & (2019-2024) Table 19. Global Key Players of Gene Delivery System, Headquarters and Area Served Table 20. Global Key Players of Gene Delivery System, Product and Application Table 21. Global Key Players of Gene Delivery System, Product and Application Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Gene Delivery System Market Size by Type (2019-2024) & (US$ Million) Table 24. Global Gene Delivery System Revenue Market Share by Type (2019-2024) Table 25. Global Gene Delivery System Forecasted Market Size by Type (2025-2030) & (US$ Million) Table 26. Global Gene Delivery System Revenue Market Share by Type (2025-2030) Table 27. Global Gene Delivery System Market Size by Application (2019-2024) & (US$ Million) Table 28. Global Gene Delivery System Revenue Share by Application (2019-2024) Table 29. Global Gene Delivery System Forecasted Market Size by Application (2025-2030) & (US$ Million) Table 30. Global Gene Delivery System Revenue Share by Application (2025-2030) Table 31. North America Gene Delivery System Market Size by Type (2019-2024) & (US$ Million) Table 32. North America Gene Delivery System Market Size by Type (2025-2030) & (US$ Million) Table 33. North America Gene Delivery System Market Size by Application (2019-2024) & (US$ Million) Table 34. North America Gene Delivery System Market Size by Application (2025-2030) & (US$ Million) Table 35. North America Gene Delivery System Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 36. North America Gene Delivery System Market Size by Country (2019-2024) & (US$ Million) Table 37. North America Gene Delivery System Market Size by Country (2025-2030) & (US$ Million) Table 38. Europe Gene Delivery System Market Size by Type (2019-2024) & (US$ Million) Table 39. Europe Gene Delivery System Market Size by Type (2025-2030) & (US$ Million) Table 40. Europe Gene Delivery System Market Size by Application (2019-2024) & (US$ Million) Table 41. Europe Gene Delivery System Market Size by Application (2025-2030) & (US$ Million) Table 42. Europe Gene Delivery System Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 43. Europe Gene Delivery System Market Size by Country (2019-2024) & (US$ Million) Table 44. Europe Gene Delivery System Market Size by Country (2025-2030) & (US$ Million) Table 45. China Gene Delivery System Market Size by Type (2019-2024) & (US$ Million) Table 46. China Gene Delivery System Market Size by Type (2025-2030) & (US$ Million) Table 47. China Gene Delivery System Market Size by Application (2019-2024) & (US$ Million) Table 48. China Gene Delivery System Market Size by Application (2025-2030) & (US$ Million) Table 49. Asia Gene Delivery System Market Size by Type (2019-2024) & (US$ Million) Table 50. Asia Gene Delivery System Market Size by Type (2025-2030) & (US$ Million) Table 51. Asia Gene Delivery System Market Size by Application (2019-2024) & (US$ Million) Table 52. Asia Gene Delivery System Market Size by Application (2025-2030) & (US$ Million) Table 53. Asia Gene Delivery System Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 54. Asia Gene Delivery System Market Size by Region (2019-2024) & (US$ Million) Table 55. Asia Gene Delivery System Market Size by Region (2025-2030) & (US$ Million) Table 56. Middle East, Africa, and Latin America Gene Delivery System Market Size by Type (2019-2024) & (US$ Million) Table 57. Middle East, Africa, and Latin America Gene Delivery System Market Size by Type (2025-2030) & (US$ Million) Table 58. Middle East, Africa, and Latin America Gene Delivery System Market Size by Application (2019-2024) & (US$ Million) Table 59. Middle East, Africa, and Latin America Gene Delivery System Market Size by Application (2025-2030) & (US$ Million) Table 60. Middle East, Africa, and Latin America Gene Delivery System Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 61. Middle East, Africa, and Latin America Gene Delivery System Market Size by Country (2019-2024) & (US$ Million) Table 62. Middle East, Africa, and Latin America Gene Delivery System Market Size by Country (2025-2030) & (US$ Million) Table 63. Biogen Company Details Table 64. Biogen Business Overview Table 65. Biogen Gene Delivery System Product Table 66. Biogen Revenue in Gene Delivery System Business (2019-2024) & (US$ Million) Table 67. Biogen Recent Developments Table 68. Novartis Company Details Table 69. Novartis Business Overview Table 70. Novartis Gene Delivery System Product Table 71. Novartis Revenue in Gene Delivery System Business (2019-2024) & (US$ Million) Table 72. Novartis Recent Developments Table 73. Gilead Sciences Company Details Table 74. Gilead Sciences Business Overview Table 75. Gilead Sciences Gene Delivery System Product Table 76. Gilead Sciences Revenue in Gene Delivery System Business (2019-2024) & (US$ Million) Table 77. Gilead Sciences Recent Developments Table 78. Sarepta Therapeutics Company Details Table 79. Sarepta Therapeutics Business Overview Table 80. Sarepta Therapeutics Gene Delivery System Product Table 81. Sarepta Therapeutics Revenue in Gene Delivery System Business (2019-2024) & (US$ Million) Table 82. Sarepta Therapeutics Recent Developments Table 83. Alnylam Pharmaceuticals Company Details Table 84. Alnylam Pharmaceuticals Business Overview Table 85. Alnylam Pharmaceuticals Gene Delivery System Product Table 86. Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2019-2024) & (US$ Million) Table 87. Alnylam Pharmaceuticals Recent Developments Table 88. Amgen Company Details Table 89. Amgen Business Overview Table 90. Amgen Gene Delivery System Product Table 91. Amgen Revenue in Gene Delivery System Business (2019-2024) & (US$ Million) Table 92. Amgen Recent Developments Table 93. Spark Therapeutics Company Details Table 94. Spark Therapeutics Business Overview Table 95. Spark Therapeutics Gene Delivery System Product Table 96. Spark Therapeutics Revenue in Gene Delivery System Business (2019-2024) & (US$ Million) Table 97. Spark Therapeutics Recent Developments Table 98. Akcea Therapeutics Company Details Table 99. Akcea Therapeutics Business Overview Table 100. Akcea Therapeutics Gene Delivery System Product Table 101. Akcea Therapeutics Revenue in Gene Delivery System Business (2019-2024) & (US$ Million) Table 102. Akcea Therapeutics Recent Developments Table 103. bluebird bio Company Details Table 104. bluebird bio Business Overview Table 105. bluebird bio Gene Delivery System Product Table 106. bluebird bio Revenue in Gene Delivery System Business (2019-2024) & (US$ Million) Table 107. bluebird bio Recent Developments Table 108. Sunway Biotech Company Details Table 109. Sunway Biotech Business Overview Table 110. Sunway Biotech Gene Delivery System Product Table 111. Sunway Biotech Revenue in Gene Delivery System Business (2019-2024) & (US$ Million) Table 112. Sunway Biotech Recent Developments Table 113. SIBIONO Company Details Table 114. SIBIONO Business Overview Table 115. SIBIONO Gene Delivery System Product Table 116. SIBIONO Revenue in Gene Delivery System Business (2019-2024) & (US$ Million) Table 117. SIBIONO Recent Developments Table 118. AnGes Company Details Table 119. AnGes Business Overview Table 120. AnGes Gene Delivery System Product Table 121. AnGes Revenue in Gene Delivery System Business (2019-2024) & (US$ Million) Table 122. AnGes Recent Developments Table 123. Orchard Therapeutics Company Details Table 124. Orchard Therapeutics Business Overview Table 125. Orchard Therapeutics Gene Delivery System Product Table 126. Orchard Therapeutics Revenue in Gene Delivery System Business (2019-2024) & (US$ Million) Table 127. Orchard Therapeutics Recent Developments Table 128. Human Stem Cells Institute Company Details Table 129. Human Stem Cells Institute Business Overview Table 130. Human Stem Cells Institute Gene Delivery System Product Table 131. Human Stem Cells Institute Revenue in Gene Delivery System Business (2019-2024) & (US$ Million) Table 132. Human Stem Cells Institute Recent Developments Table 133. Research Programs/Design for This Report Table 134. Key Data Information from Secondary Sources Table 135. Key Data Information from Primary Sources List of Figures Figure 1. Global Gene Delivery System Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Figure 2. Global Gene Delivery System Market Share by Type: 2023 VS 2030 Figure 3. Viral Gene Delivery System Features Figure 4. Non-viral Gene Delivery System Features Figure 5. Global Gene Delivery System Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Figure 6. Global Gene Delivery System Market Share by Application: 2023 VS 2030 Figure 7. Neurological Diseases Case Studies Figure 8. Cancer Case Studies Figure 9. Others Case Studies Figure 10. Gene Delivery System Report Years Considered Figure 11. Global Gene Delivery System Market Size (US$ Million), Year-over-Year: 2019-2030 Figure 12. Global Gene Delivery System Market Size, (US$ Million), 2019 VS 2023 VS 2030 Figure 13. Global Gene Delivery System Market Share by Region: 2023 VS 2030 Figure 14. Global Gene Delivery System Market Share by Players in 2023 Figure 15. Global Top Gene Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Delivery System as of 2023) Figure 16. The Top 10 and 5 Players Market Share by Gene Delivery System Revenue in 2023 Figure 17. North America Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 18. North America Gene Delivery System Market Share by Type (2019-2030) Figure 19. North America Gene Delivery System Market Share by Application (2019-2030) Figure 20. North America Gene Delivery System Market Share by Country (2019-2030) Figure 21. United States Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 22. Canada Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 23. Europe Gene Delivery System Market Size YoY (2019-2030) & (US$ Million) Figure 24. Europe Gene Delivery System Market Share by Type (2019-2030) Figure 25. Europe Gene Delivery System Market Share by Application (2019-2030) Figure 26. Europe Gene Delivery System Market Share by Country (2019-2030) Figure 27. Germany Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 28. France Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 29. U.K. Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 30. Italy Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 31. Russia Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 32. Nordic Countries Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 33. China Gene Delivery System Market Size YoY (2019-2030) & (US$ Million) Figure 34. China Gene Delivery System Market Share by Type (2019-2030) Figure 35. China Gene Delivery System Market Share by Application (2019-2030) Figure 36. Asia Gene Delivery System Market Size YoY (2019-2030) & (US$ Million) Figure 37. Asia Gene Delivery System Market Share by Type (2019-2030) Figure 38. Asia Gene Delivery System Market Share by Application (2019-2030) Figure 39. Asia Gene Delivery System Market Share by Region (2019-2030) Figure 40. Japan Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 41. South Korea Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 42. China Taiwan Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 43. Southeast Asia Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 44. India Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 45. Australia Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 46. Middle East, Africa, and Latin America Gene Delivery System Market Size YoY (2019-2030) & (US$ Million) Figure 47. Middle East, Africa, and Latin America Gene Delivery System Market Share by Type (2019-2030) Figure 48. Middle East, Africa, and Latin America Gene Delivery System Market Share by Application (2019-2030) Figure 49. Middle East, Africa, and Latin America Gene Delivery System Market Share by Country (2019-2030) Figure 50. Brazil Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 51. Mexico Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 52. Turkey Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 53. Saudi Arabia Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 54. Israel Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 55. GCC Countries Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million) Figure 56. Biogen Revenue Growth Rate in Gene Delivery System Business (2019-2024) Figure 57. Novartis Revenue Growth Rate in Gene Delivery System Business (2019-2024) Figure 58. Gilead Sciences Revenue Growth Rate in Gene Delivery System Business (2019-2024) Figure 59. Sarepta Therapeutics Revenue Growth Rate in Gene Delivery System Business (2019-2024) Figure 60. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Delivery System Business (2019-2024) Figure 61. Amgen Revenue Growth Rate in Gene Delivery System Business (2019-2024) Figure 62. Spark Therapeutics Revenue Growth Rate in Gene Delivery System Business (2019-2024) Figure 63. Akcea Therapeutics Revenue Growth Rate in Gene Delivery System Business (2019-2024) Figure 64. bluebird bio Revenue Growth Rate in Gene Delivery System Business (2019-2024) Figure 65. Sunway Biotech Revenue Growth Rate in Gene Delivery System Business (2019-2024) Figure 66. SIBIONO Revenue Growth Rate in Gene Delivery System Business (2019-2024) Figure 67. AnGes Revenue Growth Rate in Gene Delivery System Business (2019-2024) Figure 68. Orchard Therapeutics Revenue Growth Rate in Gene Delivery System Business (2019-2024) Figure 69. Human Stem Cells Institute Revenue Growth Rate in Gene Delivery System Business (2019-2024) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed
01. サンプル提供
ご購入前にサンプル(英語、日本語)が提供可能。
02. カスタマイズサービス
レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。
03. プロフェッショナルな日本語翻訳
AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。
04. 多言語コミュニケーション
日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。
05. お支払方法
銀行振込(納品後、ご請求書送付)。
06. アフターサービス
ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。
請求書払いの場合:
レポート選択
見積もり依頼
メールでのご注文
入手(英語版は2〜4営業日、日本語版は8〜10営業日)
決済(後払い)
クレジットカード決済の場合:
レポート選択
ウェブサイトでのご注文
決済
入手(英語版は2〜4営業日、日本語版は8〜10営業日)